Boyer B P, Ryerson C C, Reynolds H S, Zambon J J, Genco R J, Snyder B
Johnson & Johnson Cllrical Diagnostics, Rochester, NY 14650-2117, USA.
J Clin Periodontol. 1996 May;23(5):477-84. doi: 10.1111/j.1600-051x.1996.tb00578.x.
Studies were performed to evaluate the detection of disease-associated bacterial colonization in adult periodontitis patients by the antibody-based Evalusite TestTM (Eastman Kodak Company). The association of test results with disease was assessed by collecting 104 duplicate subgingival plaque samples from 26 patients. Samples were tested for Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis and Prevotella intermedia using both microbiological culture and the immunoassay test. The sensitivity and specificity of the 2 methods was calculated using %s of positive results in deep periodontal pockets and negative results in shallow subgingival sites. A cutoff >10(4) cultivable counts yielded the greatest discrimination between health and disease on a cross-sectional basis and established this threshold as clinically relevant for the detection of disease-associated levels of bacterial colonization by these three microorganisms. The clinical detection limit of the immunoassay test was observed to coincide with this threshold of >10(4) cultivable counts. Microbiological testing of the 4 deepest pockets using the immunoassay test was determined to be sufficient to yield a 90% confidence of detecting positive patients in a study with 59 adult subjects. The immunoassay test method was also demonstrated to be effective at detecting bacterial colonization in sets of paper point samples that were pooled for analysis. An overall agreement of 94% (288 of 306) was observed when comparing test results for duplicate sets of pooled and individual samples collected from 51 patients. These studies demonstrate that the Evalusite Test is an effective method for detecting clinically relevant colonization by the test bacteria in patients at risk for periodontal disease.
开展了多项研究,以评估基于抗体的Evalusite TestTM(伊士曼柯达公司)对成年牙周炎患者疾病相关细菌定植的检测情况。通过收集26例患者的104份重复龈下菌斑样本,评估检测结果与疾病的相关性。使用微生物培养和免疫分析检测对样本进行检测,以确定伴放线放线杆菌、牙龈卟啉单胞菌和中间普氏菌的存在情况。利用深牙周袋中的阳性结果百分比和浅龈下部位的阴性结果百分比计算这两种方法的敏感性和特异性。在横断面研究中,培养计数>10(4)时对健康和疾病的区分度最大,并将该阈值确定为检测这三种微生物疾病相关细菌定植水平的临床相关阈值。观察到免疫分析检测的临床检测限与>10(4)培养计数的阈值一致。在一项针对59名成年受试者的研究中,使用免疫分析检测对4个最深牙周袋进行微生物检测,足以有90%的把握检测出阳性患者。免疫分析检测方法在检测合并用于分析的纸尖样本组中的细菌定植方面也被证明是有效的。比较从51例患者收集的合并样本和单个样本的重复组的检测结果时,总体一致性为94%(306例中的288例)。这些研究表明,Evalusite Test是检测牙周病风险患者中检测细菌临床相关定植的有效方法。